位置:首页 > 蛋白库 > ILF3A_XENLA
ILF3A_XENLA
ID   ILF3A_XENLA             Reviewed;         897 AA.
AC   Q91550; Q9DEU4;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   02-MAR-2010, sequence version 2.
DT   03-AUG-2022, entry version 96.
DE   RecName: Full=Interleukin enhancer-binding factor 3-A;
DE   AltName: Full=CCAAT box transcription factor subunit {ECO:0000303|PubMed:9710639};
DE   AltName: Full=Double-stranded RNA-binding protein 4F.1 {ECO:0000303|PubMed:7922339};
DE            Short=DsRNA-binding protein 4F.1 {ECO:0000312|EMBL:AAA19960.1};
GN   Name=ilf3-a; Synonyms=ilf3, ubp3 {ECO:0000303|PubMed:8631310};
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAA19960.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), RNA-BINDING, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Ovary {ECO:0000312|EMBL:AAA19960.1};
RX   PubMed=7922339; DOI=10.1016/s0960-9822(00)00069-5;
RA   Bass B.L., Hurst S.R., Singer J.D.;
RT   "Binding properties of newly identified Xenopus proteins containing dsRNA-
RT   binding motifs.";
RL   Curr. Biol. 4:301-314(1994).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAG22859.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, RNA-BINDING, SUBCELLULAR
RP   LOCATION, IDENTIFICATION IN A RIBONUCLEOPROTEIN COMPLEX WITH YBX2,
RP   DEVELOPMENTAL STAGE, AND MUTAGENESIS OF PHE-433 AND PHE-552.
RX   PubMed=10899122; DOI=10.1093/emboj/19.14.3683;
RA   Brzostowski J., Robinson C., Orford R., Elgar S., Scarlett G., Peterkin T.,
RA   Malartre M., Kneale G., Wormington M., Guille M.;
RT   "RNA-dependent cytoplasmic anchoring of a transcription factor subunit
RT   during Xenopus development.";
RL   EMBO J. 19:3683-3693(2000).
RN   [3] {ECO:0000305}
RP   IDENTIFICATION OF THE MRNA IN A RIBONUCLEOPROTEIN COMPLEX.
RX   PubMed=8631310; DOI=10.1002/j.1460-2075.1996.tb00424.x;
RA   Wormington M., Searfoss A.M., Hurney C.A.;
RT   "Overexpression of poly(A) binding protein prevents maturation-specific
RT   deadenylation and translational inactivation in Xenopus oocytes.";
RL   EMBO J. 15:900-909(1996).
RN   [4] {ECO:0000305}
RP   FUNCTION, IDENTIFICATION IN THE CBTF COMPLEX, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=9710639; DOI=10.1128/mcb.18.9.5557;
RA   Orford R.L., Robinson C., Haydon J.M., Patient R.K., Guille M.J.;
RT   "The maternal CCAAT box transcription factor which controls GATA-2
RT   expression is novel and developmentally regulated and contains a double-
RT   stranded-RNA-binding subunit.";
RL   Mol. Cell. Biol. 18:5557-5566(1998).
RN   [5] {ECO:0000305}
RP   PHOSPHORYLATION.
RA   Elgar S.J.;
RL   Thesis (2001), University of Portsmouth, United Kingdom.
RN   [6] {ECO:0000305}
RP   FUNCTION, RNA-BINDING, DNA-BINDING, AND MUTAGENESIS OF PHE-433 AND PHE-552.
RX   PubMed=15452137; DOI=10.1074/jbc.m406107200;
RA   Scarlett G.P., Elgar S.J., Cary P.D., Noble A.M., Orford R.L., Kneale G.G.,
RA   Guille M.J.;
RT   "Intact RNA-binding domains are necessary for structure-specific DNA
RT   binding and transcription control by CBTF122 during Xenopus development.";
RL   J. Biol. Chem. 279:52447-52455(2004).
RN   [7] {ECO:0000305}
RP   PHOSPHORYLATION.
RA   Cazanove O.M.P.;
RL   Thesis (2006), University of Portsmouth, United Kingdom.
RN   [8] {ECO:0000305}
RP   FUNCTION, DNA-BINDING, AND METHYLATION.
RX   PubMed=18636753; DOI=10.1021/bi7008486;
RA   Cazanove O., Batut J., Scarlett G., Mumford K., Elgar S., Thresh S.,
RA   Neant I., Moreau M., Guille M.;
RT   "Methylation of Xilf3 by Xprmt1b alters its DNA, but not RNA, binding
RT   activity.";
RL   Biochemistry 47:8350-8357(2008).
RN   [9] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=19665599; DOI=10.1016/j.bbagrm.2009.07.007;
RA   Llewellyn K.J., Cary P.D., McClellan J.A., Guille M.J., Scarlett G.P.;
RT   "A-form DNA structure is a determinant of transcript levels from the
RT   Xenopus gata2 promoter in embryos.";
RL   Biochim. Biophys. Acta 1789:675-680(2009).
CC   -!- FUNCTION: RNA-binding protein that plays an essential role in the
CC       biogenesis of circular RNAs (circRNAs) which are produced by back-
CC       splicing circularization of pre-mRNAs. Within the nucleus, promotes
CC       circRNAs processing by stabilizing the regulatory elements residing in
CC       the flanking introns of the circularized exons (By similarity). Plays
CC       thereby a role in the back-splicing of a subset of circRNAs (By
CC       similarity). As a consequence, participates in a wide range of
CC       transcriptional and post-transcriptional processes (By similarity).
CC       Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of
CC       target mRNAs (By similarity). Upon viral infection, ILF3 accumulates in
CC       the cytoplasm and participates in the innate antiviral response (By
CC       similarity). Mechanistically, ILF3 becomes phosphorylated and activated
CC       by the double-stranded RNA-activated protein kinase/PKR which releases
CC       ILF3 from cellular mature circRNAs. In turn, unbound ILF3 molecules are
CC       able to interact with and thus inhibit viral mRNAs (By similarity). Has
CC       a cytoplasmic role early in development as part of a ribonucleoprotein
CC       (mRNP) complex which may regulate mRNA transport and/or translation.
CC       Following nuclear localization at the mid-blastula transition, acts as
CC       a transcription factor and binds the 5'-CCAAT-3' promoter sequence to
CC       regulate transcription of the gata2 gene as a subunit of the CCAAT box
CC       transcription factor (CBTF). Its role as an mRNP component negatively
CC       regulates its activity as a transcription factor by precluding its
CC       nuclear localization (PubMed:10899122, PubMed:15452137,
CC       PubMed:18636753, PubMed:19665599, PubMed:7922339, PubMed:9710639).
CC       {ECO:0000250|UniProtKB:Q12906, ECO:0000269|PubMed:10899122,
CC       ECO:0000269|PubMed:15452137, ECO:0000269|PubMed:18636753,
CC       ECO:0000269|PubMed:19665599, ECO:0000269|PubMed:7922339,
CC       ECO:0000269|PubMed:9710639}.
CC   -!- SUBUNIT: A component of a ybx2/frgy2-containing mRNA-ribonucleoprotein
CC       (mRNP) complex. Also a component of the CCAAT box transcription factor
CC       (CBTF) complex. {ECO:0000269|PubMed:10899122,
CC       ECO:0000269|PubMed:8631310, ECO:0000269|PubMed:9710639}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10899122,
CC       ECO:0000269|PubMed:9710639}. Cytoplasm {ECO:0000269|PubMed:10899122,
CC       ECO:0000269|PubMed:9710639}. Note=Cytoplasmic in fertilized eggs, then
CC       translocates to the nucleus prior to gastrulation. RNA-binding is
CC       required for cytoplasmic retention during early development, and
CC       nuclear translocation at the mid-blastula transition (MBT) is probably
CC       coupled to the degradation of maternal mRNA that occurs at that stage.
CC       {ECO:0000269|PubMed:10899122, ECO:0000269|PubMed:9710639}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:10899122}; Synonyms=CBTF122
CC       {ECO:0000269|PubMed:10899122}, p122 {ECO:0000269|PubMed:9710639};
CC         IsoId=Q91550-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:7922339}; Synonyms=CBTF98
CC       {ECO:0000269|PubMed:10899122};
CC         IsoId=Q91550-2; Sequence=VSP_053194, VSP_053195;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the ectoderm (at protein
CC       level). {ECO:0000269|PubMed:9710639}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically
CC       throughout early development (at protein level). Isoform 1 accumulates
CC       throughout oogenesis but isoform 2 is translationally masked until
CC       oocyte maturation. {ECO:0000269|PubMed:10899122,
CC       ECO:0000269|PubMed:7922339}.
CC   -!- PTM: Phosphorylated. Phosphorylation affects nuclear translocation.
CC       {ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
CC   -!- PTM: Methylated by protein arginine N-methyltransferase 1 (prmt1b) in
CC       the RGG-rich domain. Methylation decreases DNA-binding and thereby
CC       decreases transcription of the gata2 gene, but does not regulate dsRNA
CC       binding or subcellular localization. {ECO:0000269|PubMed:18636753}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG22859.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07155; AAA19960.1; -; mRNA.
DR   EMBL; AY008299; AAG22859.1; ALT_FRAME; mRNA.
DR   PIR; I51652; I51652.
DR   RefSeq; XP_018094990.1; XM_018239501.1. [Q91550-2]
DR   RefSeq; XP_018094991.1; XM_018239502.1. [Q91550-2]
DR   AlphaFoldDB; Q91550; -.
DR   SMR; Q91550; -.
DR   IntAct; Q91550; 1.
DR   DNASU; 399197; -.
DR   GeneID; 399197; -.
DR   CTD; 399197; -.
DR   Xenbase; XB-GENE-494371; ilf3.S.
DR   Proteomes; UP000186698; Chromosome 3S.
DR   Bgee; 399197; Expressed in egg cell and 19 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   Gene3D; 3.30.460.10; -; 2.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR006561; DZF_dom.
DR   InterPro; IPR033099; ILF3/NF90.
DR   InterPro; IPR043519; NT_sf.
DR   PANTHER; PTHR45762:SF4; PTHR45762:SF4; 3.
DR   Pfam; PF00035; dsrm; 2.
DR   Pfam; PF07528; DZF; 1.
DR   SMART; SM00358; DSRM; 2.
DR   SMART; SM00572; DZF; 1.
DR   PROSITE; PS50137; DS_RBD; 2.
DR   PROSITE; PS51703; DZF; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Cytoplasm; Developmental protein;
KW   DNA-binding; Methylation; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; RNA-binding; Transcription; Transcription regulation.
FT   CHAIN           1..897
FT                   /note="Interleukin enhancer-binding factor 3-A"
FT                   /id="PRO_0000391689"
FT   DOMAIN          5..379
FT                   /note="DZF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01040"
FT   DOMAIN          399..468
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          521..587
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   REGION          52..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          364..403
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..502
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          627..650
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          708..797
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           372..390
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        68..83
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        373..400
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        718..744
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        745..797
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         681..695
FT                   /note="QFYSNGGASGNAGGG -> DFFTDCYGYHDFASA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7922339"
FT                   /id="VSP_053194"
FT   VAR_SEQ         696..897
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7922339"
FT                   /id="VSP_053195"
FT   MUTAGEN         433
FT                   /note="F->A: Abolishes mRNA-binding and cytoplasmic
FT                   retention, localizing predominantly to the nucleus from
FT                   early development. Also disrupts DNA-binding; when
FT                   associated with A-552."
FT                   /evidence="ECO:0000269|PubMed:10899122,
FT                   ECO:0000269|PubMed:15452137"
FT   MUTAGEN         552
FT                   /note="F->A: Abolishes mRNA-binding and cytoplasmic
FT                   retention, localizing predominantly to the nucleus from
FT                   early development. Also disrupts DNA-binding; when
FT                   associated with A-433."
FT                   /evidence="ECO:0000269|PubMed:10899122,
FT                   ECO:0000269|PubMed:15452137"
FT   CONFLICT        157
FT                   /note="V -> I (in Ref. 2; AAG22859)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        540
FT                   /note="L -> M (in Ref. 1; AAA19960)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   897 AA;  98121 MW;  1AD98A9488345C85 CRC64;
     MRPMRIFLND DRHVMAKHSV VYPTQEELEA VQNMVSHTER ALKAVSDWID QQEKDCSGEQ
     EQPMAEETET TEEGKDSEMK TGENPTRTLR GVMRVGLVAK GLLLKGDLDL ELVLLCRDKP
     TISLLKRVAD NLVLQFETVS EDKYEVIQNI REALIVVKST KEPPLTLNIR LTSPLVREEM
     EKLSAGETLT VSDPPDVLDR HKCLAALASL RHAKWFQARA NGLKSCVIVI RVLRDLCTRV
     PTWEPLRGWP LELLCEKAIG TANRPMGAGE ALRRVLECLS SGILMPDGSG LYDPCEKDAS
     DALEHLERQQ REDITQSAQH ALRLAAFGQL HKVLGMDPLP SKMPKKTKVE TPVIDYTVQI
     PPSTTYAMPP LKRPIEEDGD DKSPSKKKKK IQKKDEKSEP PQVMNALMRL NQLKPGLQYK
     LISQTGPVHA PVFTMSVEVD DKTFEASGPS KKTAKLHVAV KVLQDMGLPT GMEEKEEGTD
     ESEQKPVVQT PAQPDDSAEV DSAALDQAES AKQQGPILTK HGKNPVMELN EKRRGLKYEL
     ISETGGSHDK RFVMEVEVDG VKFQGSGSNK KVAKAYAALS ALEKLFPDYT MYTEAPKKKR
     PPMMPRGGPK FAGKHNQGFG MMYSEVPPPQ AMRGRGRGGM NRGRGRGRGG FGGGYMNSGG
     YGGGYGGNYN YQTSATAGYS QFYSNGGASG NAGGGGAGTG GYSSYYQGDS YSAPTPPKPF
     VNKKPPPPQQ QQQQQPPPQH ASNPPKPSYN QGYQGHQGGQ QQQQQQQQQQ TYNQNQYSNY
     GPPQKQKGGY NQGAQGAGSG GSYNYSNSYT GGTAPLGTAV ERVQEGEAAA LTQRQALVTT
     QAHTPAMVEP AVLRRTKVTR SLITIKVPPD RTTVALQIIT SSLREELGVT AGIQNTT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024